Try our Advanced Search for more refined results
Searching dockets in Crown Laboratories Inc x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Civil Rights: Jobs | Missouri Eastern
Memorandum in Support of Motion
MEMORANDUM in Support of Motion re 6 MOTION to Compel Arbitration and to Stay Proceedings and to Compel Arbitration filed by Defendant Crown Laboratories, Inc.. (Welply, Justin)
Defend Trade Secrets Act (of 2016) | Tennessee Middle
Order Order Staying Case ~Util - Terminate Motions
ORDER: Pending before the Court is the "Joint Status Report and Motion to Stay Certain Deadlines" (Doc. No. 539 , "Motion") filed by Allergan, Inc., Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., and Allergan Sales, LLC (collectively "Plaintiffs") and Revance Therapeutics, Inc. ("Defendant," and collectively with Plaintiffs, the "Parties"). The Motion (Doc. No. 539 ), being jointly made and otherwise well-taken, is GRANTED. Accordingly, the Parties shall have until September 3, 2026, to file an additional status update with the Court regarding their case-resolution efforts. All deadlines and proceedings in this matter will remain STAYED pending the Parties' September 3, 2026, status update. Signed by District Judge Eli J. Richardson on 8/3/2026. (DOCKET TEXT SUMMARY ONLY-ATTORNEYS MUST OPEN THE PDF AND READ THE ORDER.) (sh)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
Phone
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 UK may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.